Professor Michael Bourke
20
2
4
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
30.0%
6 terminated/withdrawn out of 20 trials
62.5%
-24.0% vs industry average
5%
1 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Endoscopic Characteristics of Colonic Tumours
Role: lead
Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach
Role: lead
Australian Barrett's Cohort With Dysplasia and Early Cancer Study
Role: lead
Australian Multicentre Colonic Endoscopic Mucosal Resection Study
Role: lead
Comparison Between White Light Endoscopy and Bright Narrow Band Imaging in Diagnosis Colonic Adenomas.
Role: lead
Failed/Difficult Colonoscopy Outcomes
Role: lead
Circumferential Submucosal Incision Endoscopic Mucosal Resection Versus Conventional Endoscopic Mucosal Resection of Colonic Polyps
Role: lead
Non-invasive Risk Stratification of CR AMN/SSP
Role: lead
Upper GI Outcomes Following EMR
Role: lead
Prophylactic Coagulation for the Prevention of Bleeding in Endoscopic Mucosal Resection of Large Sessile Colonic Polyps
Role: lead
The Australian Colonic Advanced Mucosal Neoplasia and Endoscopic Resection Study
Role: lead
Long-term Outcomes of Endoscopic Resection (ER) of Lesions of the Duodenum and Ampulla
Role: lead
Clip Placement Following Endoscopic Mucosal Resection - Randomised Trial
Role: lead
Comparison Rectal Endoscopic Submucosal Dissection to Endoscopic Mucosal Resection
Role: lead
Barretts oEsophageal Resection With Steroid Therapy Trial
Role: lead
Endoscopic Characteristics of Duodenal and Ampullary Lesions
Role: lead
Long Term Barrett's Endoscopic Mucosal Resection Study
Role: lead
Fully Coated, Removable, Self-expanding Oesophageal Stents for Preventing Strictures Following Complete Barretts Excision.
Role: lead
Cold Polypectomy Site Study
Role: lead
Soft Coagulation for the Prevention of Adenoma Recurrence
Role: lead
All 20 trials loaded